113 results
S-3
PASG
Passage Bio Inc
4 Mar 24
Shelf registration
4:09pm
research collaboration with GTP provides us with access to one of the premier research institutions in the world for the discovery and preclinical … for certain rare monogenic and certain non-rare, non-monogenic, or large, CNS disorders, subject to certain limitations. We also have access to platform
8-K
EX-99.2
at54yovut74u2
13 Nov 23
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
7:00am
8-K
EX-99.1
rjk1qgmc scy34eg6k
13 Nov 23
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
7:00am
8-K
EX-99.1
dzcxjlr666h ttvnjyag
7 Aug 23
Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business Highlights
7:15am
8-K
EX-99.2
hl3gbem
7 Aug 23
Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business Highlights
7:15am
8-K
EX-99.1
73ts6sjh4w9s94ytja
11 May 23
Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights
7:09am
8-K
EX-99.2
l1l24yaqe8lan5qmjz
11 May 23
Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights
7:09am
PRE 14A
uxgi owivalz
3 Apr 23
Preliminary proxy
4:05pm
8-K
EX-99.1
p0syfwjlt2 yvhve2sp
14 Dec 22
Passage Bio Announces Positive Interim Clinical Data from First Six Patients with GM1 Gangliosidosis in Imagine-1 Study
7:00am
8-K
EX-3.1
fes 6yg65w
2 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:14pm